You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 29 No. 4, October 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  BRIEF COMMUNICATIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Permanent Dementia in Idiopathic Parkinsonism Treated With Levodopa

Sheldon M. Wolf, MD; Richard L. Davis, MD

Arch Neurol. 1973;29(4):276-278.


Abstract

An acute confusional-hallucinatory syndrome, followed by stupor and permanent dementia occurred in a patient with mild idopathic parkinsonism receiving trihexy-phenidyl, amantadine, and levodopa. During the stuporous period, his eyes were divergent, with absent oculocephalic reflexes. There were no abnormalities of other cranial nerve functions or long tract signs. Intravenous doses of pyridoxine were of no benefit. The electroencephalogram was diffusely slow. Results of laboratory studies were unremarkable, except for mild hydrocephalus ex vacuo. Seventeen days after onset, he began to recover from stupor, and became alert but profoundly demented until his death four months later. Neuropathological changes included depigmentation, neuronal loss, gliosis and Lewy bodies in the substantia nigra, mild hydrocephalus, mild atherosclerotic changes in basilar and carotid arteries, and a few tiny cerebellar infarcts. Pathological changes did not explain the acute illness.



Author Affiliations

Los Angeles

From the Southern California Permanente Medical Group (Dr. Wolf); Cajal Laboratory of Neuropathology, Los Angeles County/USC Medical Center (Dr. Davis); and University of Southern California School of Medicine (Drs. Wolf and Davis), Los Angeles.


Footnotes

Accepted for publication June 13, 1973.

Reprint requests to 1526 N Edgemont St, Los Angeles 90027 (Dr. Wolf).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dementia With Lewy Bodies
Galvin
Arch Neurol 2003;60:1332-1335.
FULL TEXT  

Intellectual Impairment in Parkinson's Disease: Clinical, Pathologic, and Biochemical Correlates
Cummings
J Geriatr Psychiatry Neurol 1988;1:24-36.
ABSTRACT  

Drugs Five Years Later: Levodopa
YAHR
ANN INTERN MED 1975;83:677-682.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.